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Abstract
Appropriate  regulation  of  microvascular  blood  flow  in  the  neonate  is  crucial  for
cardiorespiratory stability  and survival  in  the period immediately following birth.
Inappropriate  microvascular  dilatation  in  the  first  few days  of  extrauterine  life  is
associated with poor outcomes in preterm neonates. Male very preterm neonates (≤28
weeks completed gestation) have significantly higher flows than females of the same
gestational age. This is of clinical importance as preterm males are twice as likely to die
as females. Very little is known about the mechanisms underlying microvascular tone
regulation in the perinatal period. Previous studies suggest a role for the gasotransmit‐
ters nitric oxide and carbon monoxide; however, differences in levels of these molecules
do not account for all the variation observed, suggesting another player. In this chapter,
the role of the third gasotransmitter—hydrogen sulphide—as a potential mediator of
microvascular (dys)function in the preterm is explored.
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1. Introduction
The newborn period represents a time of high mortality and morbidity. In the developed and
developing world, perinatal mortality is the major contributor to infant, and thus child mortality
[1],  with the preterm infant at  the greatest  risk of  poor outcomes.  In Western countries,
approximately 10% of infants are delivered prematurely (defined as less than 37 completed
weeks of gestation) [2]. Both mortality and morbidity increase substantially with decreasing
gestation at birth, as does the risk of long‐term disability. Thus, the neonatal period, and
prematurity in particular, represents a significant burden for the infant, the family and society.
There is a marked sex difference in many of these outcomes, with males doing significantly
worse, the causes of which are not fully elucidated. Studies of the microcirculation may be
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important in understanding both the general and sex‐specific risks as peripheral blood flow is
subject to considerable changes during the first days of postnatal life, a period of marked
circulatory vulnerability, especially in preterm infants.
2. Circulatory transition
There is an increasing body of recent work demonstrating the relationship between peripheral
microvascular blood flow and measures of neonatal physiological and cardiorespiratory
stability during the transitional period. These studies have shown that the evaluation of the
peripheral microcirculation is useful for the assessment of cardiovascular changes within the
initial extrauterine period [3, 4]. In the newborn, the skin represents a significant microvascular
bed, both because of its size and functional perinatal changes. Measurement of cutaneous
microvascular behaviour may be more useful at identifying individuals at risk of cardiovas‐
cular compromise than traditional blood pressure monitoring, as decreases in peripheral blood
flow can be identified before blood pressure drops in states of compensatory peripheral
vasoconstriction. Peripheral blood flow may increase early in vasodilatory shock, despite
stable systemic blood pressure for some time after onset [5]. This suggests that peripheral
microvascular tissue flow evaluation may be useful for early detection of cardiovascular
compromise. In addition, the regulatory mechanisms of the peripheral microcirculation
contribute to (and may reflect) the underlying neuroendocrine responses to cardiovascular
compromise [6, 7]. Finally, the skin allows non‐invasive microvascular measurement, a
prerequisite for human newborn studies of the microcirculation.
In adults, blood enters the skin through small arterioles, penetrating the subcutaneous tissue
toward the skin surface. One artery often branches into several precapillary arterioles (30–
80 μm), which pass into the venous plexuses that are organized parallel to the skin surface.
Each arteriole can divide into eight to ten capillary loops orientated perpendicular to the skin
surface, with one to three loops perfusing each skin papilla [8]. In neonates, however, this is
much less organized and the arteriolar‐venular anastomoses, and the capillary loops are
immature, with a less defined network. Capillary loops are not detectable (outside the nail
beds, palms, or soles) until 2 weeks post‐partum (and even then, are not distinguishable in all
sites until 14 weeks postnatal age or more) [9]. Development and refinement of the vascular
network continues until the formation of a more “adult‐type” network at approximately 4
months postnatal age. Despite this structural immaturity, the cutaneous microvasculature of
both term and preterm infants is capable of responding to external stimuli, such as occlusion
or local heating, from shortly after birth [4, 10].
2.1. Preterm infants
Circulatory transition is a period of marked circulatory vulnerability, especially in preterm
infants. The preterm heart is structurally and functionally immature and is not capable of
adapting to relatively small changes in preload and afterload in order to function effectively
and deliver oxygen and nutrients to tissues. Animal studies in neonatal pigs have demon‐
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strated that the preterm heart requires significantly higher levels of preload than term hearts
in order to function effectively [11, 12]. Thus, abnormal regulation of vascular resistance, with
net effects on preload and/or afterload, may play a major role in the development of cardio‐
vascular compromise in preterm infants [4, 13, 14].
The peripheral microcirculation undergoes rapid and considerable change during the initial
extrauterine period [15, 16]. Studies examining microvascular behaviour in the first 3 days of
life have reported that peripheral microvascular blood flow is significantly higher in very
preterm infants (≤28 weeks gestational age [GA]) as compared to infants born moderately
preterm (29–36 weeks GA) [4] or at full term [17]. This increased peripheral blood flow is
associated with low blood pressure, physiological instability, and adverse outcome in the initial
extrauterine period [4, 18]. Very preterm male infants, those at the greatest risk for poor short‐
and long‐term outcomes [19], have greater baseline microvascular blood flow than female
infants of the same gestational age at 24 h age [20], suggesting sex‐specific differences in the
neonatal ability to control vascular tone.
These studies demonstrate a strong relationship between microvascular flow and mean arterial
pressure. Taken together, they suggest that a large proportion of the blood volume is being
taken up by the capacitance vessels and the microcirculation in (male) preterm newborns,
leading to “functional hypovolaemia” and decreased preload. This may explain why males
are more at risk of complications in the first 24–48 h of life [19, 21].
3. Control of microvascular tone in the newborn
During rapid postnatal growth, autoregulatory mechanisms play a major role in maintaining
adequate perfusion of developing tissues. Neural and myogenic control of skin blood flow
must be rapidly established following birth to allow an effective thermoregulation in the
newborn and to ensure that metabolic demands of tissues are met [22]. It is well established
that the autonomic nervous system, particularly peripheral sympathetic nervous system
activity, plays a central role in the regulation of vascular tone in the transitional circulation of
term neonates [23]. The myogenic response contributes to autoregulation of tissue blood flow
and is not dependent upon neural innervation or the endothelium in the adult vasculature.
However, the myogenic response of juvenile arterioles isolated from Wistar rats is significantly
reduced following endothelial removal, suggesting that in juvenile arterioles endothelium‐
derived factors normally augment myogenic activity over a wide range of pressures [24]. Thus,
the endothelium may be more important in the regulation of vascular tone in the transitional
circulation compared to the more mature individual. This is likely to be even more important
in the preterm infant, where the balance of parasympathetic (vagal) tone to sympathetic drive
is relatively increased compared to term infants [25].
Endothelial cells coordinate the release of vasoactive substances which act directly upon
vascular smooth muscle cells (VSMCs) and thus elicit constriction or dilation of the blood
vessel [26]. How various vascular mediators may interact in the initial extrauterine period is
unknown at present, but elucidation of this interplay and the underlying mechanisms may
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help to understand microvascular dysfunction and cardiorespiratory instability in the early
neonatal period.
3.1. Vasoconstriction
Peripheral vascular resistance is known to correlate with the degree of sympathoadrenal
activation at birth [27]. This is due to the fact that autonomic nervous system activity is an
essential component of circulatory transition and adaptation to extrauterine life. The periph‐
eral sympathetic nervous system plays a central role in regulation of vascular tone during this
period largely via the action of norepinephrine, the main sympathetic neurotransmitter
regulating the cardiovascular system in the neonate and eliciting vasoconstriction [28]. Its
metabolite, normetanephrine, is excreted in the urine and has been used as a measure of total
body sympathoadrenal activity [29] with levels shown to be higher in female than male
newborns [23]. In that study, normetanephrine was inversely related to both baseline micro‐
vascular blood flow and physiological instability immediately following birth in preterm
neonates.
Endothelin (ET)‐1 is a primary vasoconstrictor in the pulmonary vasculature of the foetus and
neonate. ET‐1 is produced by endothelial cells in response to a number of stimuli, including
shear stress, hypoxia and ischemia [30]. ET‐1 binds to one of the three receptors: ETA, ETB1 or
ETB2 receptors, located in the underlying VSMCs. Studies in neonatal pigs suggest that all three
ET receptor subtypes are highly expressed following birth, and play distinct roles in the
newborn: in line with previous studies, ETA andETB2 receptors appear to be responsible for the
vasoconstrictive action of ET‐1, whereas binding of ET‐1 to ETB1 receptors elicits vasodilatation.
Importantly, these receptors follow a distinct expression profile: the pro‐constrictive ETA and
ETB2 receptors are more abundant in proximal vessels [31], for example, in the pulmonary
arteries and veins, respectively [32]; whereas ETB1 receptors are more abundant in the distal
vasculature, with relatively low expression in arteries [31, 32]. Evidence from newborn piglets
suggests that receptor‐affinity for ET‐1 is higher in veins than arteries, suggesting that in the
immediate postnatal period at least, the majority of the ET‐1 vasoconstrictive effect is mediated
through ETB2 receptors [32].
ET‐1 can also elicit vasodilatation through endothelium‐derived nitric oxide (NO) and
prostacyclin, by binding to endothelial ETB1 receptors. Endothelial ETB receptors are expressed
more highly in the distal than the proximal vessels [31, 33]. In the pulmonary vasculature,
ETA‐mediated contraction decreases and ETB1‐mediated NO‐dependent relaxation increases
with advancing postnatal age [34], suggesting a switch from a constricted to dilated state,
which follows the known decrease in pulmonary vascular resistance following birth, allowing
for blood oxygenation [35]. In line with this, plasma ET‐1 levels peak immediately after birth
and then gradually decrease, with concentrations in healthy term newborns more than
threefold greater than at 5 or 30 days postnatal age [36–38]. In a recent study of preterm
newborns [23], a significant increase of ET‐1 after birth was observed in very preterm neonates,
but not in more mature neonates. Interestingly, umbilical arterial ET‐1 was significantly higher
in female preterm neonates, which is of interest given the well characterised sexual dimor‐
phism in the development of respiratory distress [39]. Plasma ET‐1, however, did not correlate
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with peripheral microvascular blood flow or illness severity, suggesting that while ET‐1 may
play a significant role in the regulation of pulmonary vascular tone, it does not appear to exert
a dominant effect over systemic or peripheral microvascular tone [23].
Isoprostanes (prostaglandin‐like bioactive molecules generated by free radicals and reactive
oxygen species) are also vasoconstrictive in a number of vascular beds in the foetus and
neonate. Under normal conditions in the adult, isoprostanes are present at nanomolar
concentrations. In the newborn, however, levels are significantly higher due to the oxidative
stress of the adaptation to a rapid increase in blood oxygen tension that occurs during the
transition from fetal to neonatal life. The isoprostanes elicit vasoconstriction through a number
of pathways, including activation of prostanoid and thromboxane receptors, and tyrosine
kinase and Rho kinase pathways [40, 41]. As preterm infants are more susceptible to oxidative
stress, they have greater isoprostane concentrations, with an inverse correlation between
isoprostane levels and gestational age being observed [42]. At term, umbilical cord arterial
isoprostane concentrations are higher in male neonates compared to females of the same age
[43], which is consistent with the known vulnerability of males to oxidative stress compared
to females [44]. Whether this relationship exists at earlier gestational ages is unclear, however,
it seems unlikely that this is a major contributor to peripheral vascular tone regulation in the
preterm neonate, as it is well documented that these neonates have a loss of peripheral vascular
tone (vasodilatation) [20]. Isoprostanes, along with prostaglandins, play a major role in the
closure of the ductus arteriosus after birth, suggesting these molecules may play a more
significant role in central, rather than microvascular, vasoactive effects during circulatory
transition [41].
Overall, the balance of vasoconstrictors to vasodilators in the immediate postnatal period
appears to be relatively increased in females and more mature infants and is associated more
with the control of central than peripheral vascular tone.
3.2. Vasodilatation
Whilst the above suggests that microvascular dysregulation in the preterm newborn may be
associated with impaired vasoconstriction, there is also a potential role for abnormal peripheral
vasodilatation leading to the development of cardiovascular compromise and poor outcome
[45]. Changes in enzyme expression, receptor density, ion channel activity and intracellular
signalling pathways are all likely responsible for the changes in vascular tone regulation
observed during circulatory transition. Studies have shown, for example, that the mechanisms
mediating endothelium‐dependent vasodilatation in the femoral artery of piglets undergo a
maturational change during the first weeks of life [46].
Additionally, there are considerable variations in the contribution of vasoactive substances to
endothelium‐dependent relaxations in different tissues—it appears that nitric oxide (NO) is
the principal vasodilator in conduit arteries, whereas other mediators, such as endothelial‐
derived hyperpolarising factors (EDHF), make a significant contribution at the level of the
resistance arteries [47, 48]. Despite this clear role for other mediators, NO is the most exten‐
sively studied vasodilator in the preterm newborn [49–53], partly due to its therapeutic use for
the treatment of persistent pulmonary hypertension of the newborn.
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Vasodilatation of cerebral arterioles in the newborn pig is largely mediated by endothelial
prostanoids, with endothelial NO assuming a progressively greater role in vascular tone
regulation during subsequent postnatal maturation. Underlying this difference is a twofold to
threefold increase in both the expression and activity of endothelial nitric oxide synthase
(eNOS) between birth and 3–4 months postnatal age in cerebral microvessels [54–57]. In the
cerebral arteries of newborn sheep, NO plays a major role in endothelium‐dependent dilatation
during the first week of life [58, 59]. Interestingly, it has also been shown that in newborn lambs,
the contribution of NO to peripheral vascular tone is relatively low compared to its contribu‐
tion in the cerebral circulation [60]. This suggests a role for the involvement of other factors
regulating systemic vasodilatation, either independently or in concert with NO, during
circulatory transition; and that considerable interspecies and regional differences in vasodila‐
tor mechanisms exist. Human studies of the perinatal cerebral microvasculature rely on non‐
invasive measures such as near infrared spectroscopy or minimally invasive techniques such
as xenon cerebral blood flow assessment. Neither has been assessed in this age group in relation
to the mediators and their interactions described earlier.
3.2.1. Gasotransmitters
As the gasotransmitters, NO, carbon monoxide (CO) and hydrogen sulphide (H2S) appear to
be crucial to the dilatory component in the newborn circulation these will each be dealt with
in the following sections.
3.2.1.1. Nitric oxide
NO is known to play a central role in maintaining vascular homeostasis in the transitional
circulation [61]. Hypoxic events occurring at birth are known to upregulate eNOS expression
leading to increased NO production, eliciting vasodilatation in the systemic microvasculature
of the newborn [62, 63]. It has been hypothesised that the overproduction of NO in the perinatal
period may lead to poor control of blood flow throughout the peripheral microcirculation of
preterm infants, increasing their risk of circulatory compromise [64]. Blood pressure in the
preterm neonate is inversely correlated to cGMP levels [61]. A role may exist for NO, it’s
substrates or second messengers as potential regulators of peripheral blood flow in the preterm
infant [61, 65].
Our group, however, has previously shown that changes in human skin microvascular blood
flow in the first 3 days of life are not associated with changes in systemic NO production [45].
Additionally, it has been hypothesised that the rate of NO production by eNOS in the endo‐
thelium of peripheral microvessels is lower than would be required to activate the downstream
sGC pathway in VSMCs responsible for the excessive vasodilatation seen in premature
neonates [66, 67]. This has led to the speculation that other mechanisms may be involved in
both the production of NO in the microvasculature and its vasoactive effects on VSMCs during
the transition from fetal to neonatal circulatory systems, with NO contributing primarily to
the maintenance of baseline tone throughout this period, rather than the pathophysiological
variations that are seen in microvascular tone.
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3.2.1.2. Carbon monoxide
Carbon monoxide (CO) is produced endogenously in endothelial cells and VSMCs as a result
of catabolism of heme by the enzyme heme oxygenase (HO) [68]. Two functional HO isoforms
have been identified in humans and other species—HO‐1, the inducible isoform which is
upregulated by various stress stimuli (oxidative stress, cytokines, endotoxin and hypoxia) [69]
and plays an important role in cellular defence, and HO‐2, the constitutive isoform. Vasodila‐
tation by CO is thought to be through similar pathways to NO, with CO inducing VSMC
relaxation by the activation of cGMP‐dependent pathways [70]; however, evidence of cGMP‐
independent pathways also exists—with several papers now suggesting that CO‐induced
vasodilatation is also mediated by large conductance calcium‐activated potassium channel
(BKCa) activation leading to VSMC hyperpolarisation [71, 72].
HO‐1 plays an important role as an antioxidant, anti‐inflammatory and anti‐apoptotic
mediator in prenatal and postnatal development and in the transitional circulation of neo‐
nates [69, 71]. HO‐2 expression in the cerebral vasculature is developmentally regulated, with
significant increases in expression observed with advancing gestational age [73, 74]. HO‐2 is
highly expressed in cerebral blood vessels in the newborn piglet and in these studies CO was
shown to be a potent vasodilator in this microcirculatory bed [71].
CO is thought to play a role in maintaining vascular homeostasis in the fetal circulation, and
endogenously produced CO is known to play a role in maintaining the patency of the ductus
arteriosus (DA) in utero [75]. We have previously shown that CO is relatively increased in
males and younger infants, that is, those who exhibit increased vasodilatation and adverse
clinical outcomes [45]. However, the CO findings only explain a proportion of the difference
present in early vasodilatation events (r=0.495 at 24 h postnatal age), with differences in NO
levels apparently occurring beyond the crucial early period, suggesting at least one other
vasodilator is involved.
3.2.1.3. Hydrogen sulphide
In adults, interest is increasing in the role of a third gasotransmitter, H2S, as a vascular mediator
important in regulation of microvascular tone. H2S is produced endogenously in the vascula‐
ture in amounts capable of causing vasodilatation and thus may play a role in the regulation
of vessel dilatation and control of blood pressure [76–78]. The majority of endogenous H2S
synthesis occurs by two pyridoxal‐5′‐phosphate (PLP)‐dependent enzymes in the transsul‐
phuration pathway: cystathionine‐β‐synthase (CBS) and cystathionine‐γ‐lyase (CSE). The
substrates for these enzymes include the amino acids cysteine, homocysteine and cystathio‐
nine [79]. A third non‐PLP‐dependent enzyme 3‐mercaptopyruvate sulphurtransferase (MST)
also contributes to H2S production by the metabolism of mercaptopyruvate.
In contrast to NO and CO, H2S is proposed to exert the majority of its vasodilatory effects
through the activation and opening of transmembrane ATP‐sensitive potassium channels
(KATP) in VSMCs [80]. In VSMCs, opening of KATP channels leads to hyperpolarisation of the
cell membrane, inactivating voltage‐dependent calcium channels and resulting in VSMC
relaxation [81]. Thus, H2S has been implicated as a crucial physiological mediator of vascular
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tone that represents an alternative pathway of vascular tone control to NO and CO. Like all
the gasotransmitters, H2S is lipophilic, ensuring rapid diffusion of the gas throughout the
endothelium and VSMCs, despite its intrinsic reactivity with a diverse range of substrates [82,
83]. This diffuse production across the vessel wall and its mechanism of action qualify H2S as
an EDHF [84].
The H2S producing enzyme CBS is expressed in multiple tissues during development. In the
adult, many of these tissues, including the heart and lungs, do not express CBS [85]. In
comparison, many studies have suggested that CSE is not expressed during early mammalian
development—in human liver, CSE activity is not detectable in fetal liver or in premature or
full‐term neonatal liver samples and is not detected until several days postnatal age, with levels
comparable to that in the adult reached by 3 months postnatal age [86, 87]. Recent studies,
however, suggest that this developmental expression pattern may not be consistent across
different tissues and vascular networks. Baragatti et al. [82] have recently demonstrated gene
expression of CSE, CBS and MST in the ductus arteriosus in fetal mice (MST expression was
very low compared with CSE and CBS). The expression of CSE and CBS was localised to the
ductus with a specific distribution: CSE staining was more intense in the endothelial layer (45%
higher than in the smooth muscle layer). Conversely, CBS staining was 15% higher in the
smooth muscle layer compared to the endothelium. This supports an endothelial, CSE‐derived
source of H2S in the mammalian foetus. Leffler et al. [88] showed that H2S may also be important
in the transitional cerebral circulation of newborn piglets with endogenous H2S produced by
CSE, but not CBS, in concentrations capable of eliciting pial arteriolar dilatation.
Until recently, very little was known about the role of H2S in the transitional circulation of the
neonate. The above studies demonstrated at least some activity of both CBS and CSE in the
transitional circulation of the preterm newborn [89]. CBS expression, and to a lesser extent CSE,
is crucial for the survival of newborn animals: CBS‐deficient mice (Cbs–/– knockout) display
endothelial dysfunction, severe growth retardation and profound lethality at weaning age, as
well as the features of homocysteinemia seen in human CBS‐deficient patients [90, 91]. CSE
may be important in protecting against oxidative stress in the preterm newborn; Cth–/– mice
display greater sensitivity to oxidative stress, despite normal serum biochemistry (for example,
levels of bilirubin and glutathione) and the absence of histological abnormalities [90, 92].
Studies have now shown evidence of a role for H2S in physiological microvascular tone
regulation during circulatory transition in human infants, with higher production potentially
associated with dysregulation in the human preterm male neonate [93, 94]. In preterm neonates
(29–36 weeks completed gestation), total body turnover of H2S (measured as urinary thiosul‐
phate) positively correlates with peripheral microvascular blood flow and negatively corre‐
lates with blood pressure, supporting both a role for H2S in microvascular tone regulation [93].
This increased total body turnover of H2S was shown to be related independently to all the
major risk factors for poor outcome: gestational age, postnatal age and male sex. In these
studies, thiosulphate differences were not present in the first few hours immediately after birth,
which suggests that very preterm neonates are not born with inherently higher levels of H2S
production, but that this increases significantly following birth [93]. Potential triggers for this
could include oxidative stress [95] or inflammation [96], both of which are increased in preterm
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neonates [97]. The positive relationship of H2S turnover with microvascular blood flow, and
the inverse relationship with blood pressure in more mature neonates, suggests a physiological
role of H2S in this age group, perhaps as a counter to the increased vasoconstrictors (see above)
[98], or as a reflection of an organ specific vascular dilatation, such as in the pulmonary
circulation [99, 100].
The contribution of H2S to vasodilatation via different pathways to those of NO and CO, or
interactions with these mediators, may represent a crucial role for this gasotransmitter in
regulation, or dysregulation of microvascular tone in the neonatal microvasculature.
4. Interactions of the gasotransmitters in the neonate
It is becoming increasingly evident that the complexity of hemodynamic microvascular control
is not through the activity of single factors working in isolation, but by the interaction of all
these elements [101, 102]. This includes interactions between the three gasotransmitters in the
neonatal microcirculation (Figure 1).
Figure 1. Structural equation modelling of gasotransmitter and microvascular flow interactions in the preterm new‐
borns (males and females combined). NO promotes H2S production (Interaction 4; overall p = 0.002; males p = 0.06,
females p < 0.0001), whilst CO inhibits H2S only in female infants (Interaction 2; overall p = 0.18, males p = 0.84, females
p < 0.0001). The net result is a mild increase in the effect of all vasodilators acting on the microvasculature in males
(Interaction 5, p = 0.006) compared to the effect of H2S in isolation (model not shown). In females the model predicted a
lower contribution of H2S on microvascular blood flow when CO and NO were included in the model compared to its
effect in isolation. The model predicted covariance in the levels of NO and CO (Interaction 1) but CO had no direct
effect on microvascular blood flow (Interaction 3). Inclusion of this pathway, however, improved goodness of fit, most
markedly in females (with CO effect χ2 = 0.03, without χ2 = 0.29). The inclusion of a direct effect of CO on flow addi‐
tionally increased the predicted blood flow effect of H2S in the overall model in both sexes, suggesting a synergistic or
permissive action between these molecules. Adapted from Dyson et al. [94].
Knecht et al. [103] found in neonatal pig pial arterioles that CO responses are biphasic:
dilatation occurred in response to an acute elevation, such as that produced by inducible HO
activity following birth [104], while prolonged or sustained CO exposure caused constriction
via NOS inhibition. They speculated that such interaction between CO/HO and NO/NOS could
form a negative feedback system for the regulation of cerebrovascular tone. Importantly, the
balance of NO and CO systems is different in neonatal and adult cerebrovascular circulations
[103]. The role of NO in cerebrovascular control is less in newborn piglets compared to juvenile
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pigs, consistent with findings in human newborns [45, 55, 57, 61]. In contrast, the pial arteriolar
response to CO is greater in newborn piglets compared to older pigs or adult rats. Additionally,
they showed that whilst CO-induced dilation in older pigs and rats occurred independently
of co-factors, NO and prostacyclin were required for CO-mediated vasodilatation to occur in
the newborn [71].
In the mature circulation endogenous production of H2S appears to be enhanced by NO. H2S
is also known to promote endothelial cell NO release, leading to a threefold increase in
vasorelaxation [105, 106]. In adult rats with pulmonary hypertension, the administration of L-
arginine (the pre-cursor for NO) increases CSE expression in pulmonary artery VSMCs and
also plasma H2S concentrations [107]. It is unclear whether L-arginine itself or its metabolites
induce this upregulation but evidence that NO upregulates CSE expression and H2S synthesis
in VSMCs exists [105]. H2S can also induce an upregulation of HMOX1—the gene coding for
HO-1. By upregulating HO-1 expression, H2S can thus increase CO production eliciting further
vasodilatation. Conversely, administration of an inhibitor of CSE leads to a decrease in CO
synthesis [108, 109].
In preterm newborns, a significant positive relationship exists between NO and H2S [94].
Previous studies have reported that NO inhibits H2S production via CBS [110, 111] but induces
CSE H2S production [105]. This may suggest that in the human preterm newborn, CSE
expression is significantly modulated by NO. Evidence from animal models of prematurity
suggest that increases in H2S associated with microvascular dysregulation are driven by CSE-
dependent mechanisms: in preterm animals, H2S increases during fetal-to-neonatal transition,
with significantly higher levels of H2S produced by tissues collected at 24h postnatal age
compared to fetal tissues. Additionally, CSE contribution to total H2S increases postnatally.
H2S produced by the vasculature (both total H2S and CSE-derived H2S) correlates with
microvascular blood flow at 24h postnatal age [112]. This suggests that CSE-dependent
mechanisms drive the observed increase of H2S production, and potentially the increased
microvascular blood flow and decreased blood pressure, over the first 3 days of life in preterm
human neonates [93]. In modelling known interactions of the gasotransmitters in human
preterm neonates, a lower contribution of H2S to microvascular tone regulation in females was
predicted when the other gasotransmitters were added into the model [94]. This suggests that
the effects of either NO or CO, singly or in combination, negate the effect of H2S in these female
infants to such a degree that there is no net effect on vascular tone. This may be primarily due
to CO, which is inversely correlated with H2S and may reflect an inhibitory action of CO on
H2S [94], in line with published reports [113–115]. Thus in the preterm neonate, because of
these dimorphic responses, comparable levels of CO could be associated with microvascular
dysregulation and cardiovascular compromise in males but help protect against inappropriate
vasodilation in females [45].
4.1. Proposed mechanism of gasotransmitter-regulated microvascular vasodilatation in the
newborn
We propose a model of gasotransmitter-dependent vasodilation in the preterm newborn,
including a role for oxidative stress in driving dysregulation. It is now evident that all three
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gasotransmitters may protect against oxidative damage, but may also be cytotoxic via their
inhibition of cellular respiration (through inhibition of mitochondrial respiratory chain
cytochrome‐C‐oxidase) and through their marked pro‐inflammatory effects [116]. As in the
studies performed by Knecht et al., an acute increase in CO, driven in part by the HO‐1 response
to birth and exposure to high‐concentration oxygen during resuscitation [117], drives CO‐
mediated vasodilatation in the male preterm newborn. Due to lowered antioxidant defences,
HO‐1 upregulation persists, and the prolonged CO production inhibits NO [103]. This would
account for the transient nature of both the CO rise and increased microvascular blood flow
observed in the preterm newborn around 24 h postnatal age, which has been shown to not be
associated with NO [45]. Additionally, the transsulphuration pathway is upregulated by
oxidative stress to produce the antioxidant glutathione. H2S production is increased by this
response, driving aberrant vasodilatation and contributing to hypotension and cardiovascular
compromise in the preterm newborn.
We propose varying roles for the three gasotransmitters, allowing for regional and temporal
control of blood flow:
• Taking into account gasotransmitter level time course and actions, we propose that NO
during circulatory transition is responsible for the maintenance of basal vascular tone—as
it is in adults [118, 119]. Levels are relatively stable in the first few days of life, with increases
occurring outside the crucial early period of the first 24–48 h following birth [45]. NO in the
transitional neonate is not, however, correlated with aberrant peripheral microvascular flow.
• CO has been shown to be a crucial regulator of vascular tone in the cerebral circulation
during circulatory transition [71, 120]. It may also explain a proportion of the variance
observed in early peripheral vasodilator events [45, 94], both directly and via the sexually
dimorphic effects on other vasodilator pathways. The cerebral circulation effects of a CO
increase, such as that observed by Stark et al [45], could contribute to the greater incidence
of cerebral injury in preterm males.
• Based on our more recent studies, including metabolite measurement, production enzyme
assays and interaction modelling, we suggest that H2S is a key player in the systemic
microvasculature in the sick or preterm newborn. Further we propose that H2S is produced
by the peripheral vasculature, particularly via endothelial CSE, and that this closely
regulates microvascular tone during this critical period [112].
5. Summary
The microcirculation is structurally and functionally different in the neonate. The ability of the
newborn to appropriately distribute blood flow to key vascular beds and to maintain adequate
cardiac output is strongly linked to their survival. As cardiac function in the neonate is strongly
influenced by both preload and afterload, sex differences in peripheral vascular function in
preterm neonates may lead to differences in cardiac function, contributing to physiological
instability and thus poor outcomes. In support of this, sexual dimorphism in the functional
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integrity of the microvasculature, including appropriate control of vasodilatation, is observed
in very preterm neonates and is linked to outcome. Gestational age, postnatal age and sex all
exert significant effects on peripheral microvascular function, dysregulation of which is
associated with clinical illness severity in the neonate; however, the mechanisms by which
these factors exert their effects are largely unknown. The gasotransmitters NO, CO and H2S
represent novel mediators which may play a significant role in the regulation of microvascular
tone in the newborn: both through their individual roles but also through their potential
interactions. The studies outlined above suggest that the gasotransmitters and their interac‐
tions could influence the adverse cardiovascular outcomes seen in this population.
6. Conclusions
Cardiovascular compromise is associated with poor outcome in the preterm neonate, with
gestational age and male sex as independent risk factors for the development of hypotension
and cardiovascular compromise, amongst several other morbidities. A growing body of work
has highlighted the importance of the microvasculature in the development of cardiovascular
compromise in the preterm newborn, and thus the importance of understanding the contri‐
bution of inappropriate peripheral vasodilatation to hypotension, cardiovascular compromise
and poor neonatal outcomes.
Potential therapies aimed at either preventing or ameliorating cardiovascular compromise in
the preterm neonate must consider the role of microvascular dysfunction, driven by an
imbalance in vascular tone mediators, including the gasotransmitters, NO, CO and H2S.
Understanding the aetiology of cardiovascular compromise is crucial for the development of
better strategies for monitoring, prevention and treatment of these at risk infants.
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